Please assess the completion status of the following clinical trial:

Trial Title: Window to Hope-Evaluating a Psychological Treatment for Hopelessness Among Veterans With Traumatic Brain Injury

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria for Pilot Groups:~* Age between 18 and 89~* Determination of positive history of moderate/or severe TBI~* Ability to adequately respond to questions regarding the informed consent procedure~Exclusion Criteria for Pilot Groups:~* History of alcohol abuse in the seven days prior to baseline assessment~* History of non-alcohol substance abuse within the last 30 days prior to baseline assessment~* Same-day drug or alcohol abuse during treatment~* History of mild TBI only~* Inability to travel to the Denver VA for daily or weekly therapy sessions~Inclusion Criteria for RCT:~* Age between 18 and 65~* Determination of positive history of moderate/or severe TBI~* Beck Hopelessness Scale score of 9 or greater~* Ability to adequately respond to questions regarding the informed consent procedure~Exclusion Criteria for RCT:~* Diagnosis of neurological condition(s)~* History of alcohol abuse in the seven days prior to baseline assessment~* History of non-alcohol substance abuse within the last 30 days prior to baseline assessment~* Same-day drug or alcohol abuse during treatment~* History of mild TBI only~* Inability to travel to the Denver VA for weekly therapy sessions

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 89 Years
- Healthy Volunteers: f

Study Arms:
- WtoH Intervention (Type: EXPERIMENTAL): Window to Hope: Psychotherapy consists of 10 2-hour sessions for a maximum dose delivered of 20 hours. Therapy consists of small groups of up to 2 participants.
- Waitlist Control (Type: OTHER): Members of the Waitlist Control arm continued to receive nonconstrained usual care from the Veterans Health Administration. Those initially allocated to the Waitlist Control arm were later provided with the opportunity to cross over and receive the WtoH Intervention after Time 2.

Based on this trial design, predict the completion outcome and termination type (if applicable).